Skip to main content

and
  1. Article

    Open Access

    Recent advances in polygenic scores: translation, equitability, methods and FAIR tools

    Polygenic scores (PGS) can be used for risk stratification by quantifying individuals’ genetic predisposition to disease, and many potentially clinically useful applications have been proposed. Here, we review...

    Ruidong **ang, Martin Kelemen, Yu Xu, Laura W. Harris, Helen Parkinson in Genome Medicine (2024)

  2. Article

    Open Access

    The Ontology of Biological Attributes (OBA)—computational traits for the life sciences

    Existing phenotype ontologies were originally developed to represent phenotypes that manifest as a character state in relation to a wild-type or other reference. However, these do not include the phenotypic tr...

    Ray Stefancsik, James P. Balhoff, Meghan A. Balk, Robyn L. Ball in Mammalian Genome (2023)

  3. Article

    Open Access

    A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog

    The accurate description of ancestry is essential to interpret, access, and integrate human genomics data, and to ensure that these benefit individuals from all ancestral backgrounds. However, there are no est...

    Joannella Morales, Danielle Welter, Emily H. Bowler, Maria Cerezo in Genome Biology (2018)

  4. Article

    Open Access

    The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia

    Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessa...

    Daniel Martins-de-Souza, Murtada Alsaif, Agnes Ernst, Laura W Harris in BMC Research Notes (2012)

  5. Article

    The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus

    Administration of the DNA-alkylating agent methylazoxymethanol acetate (MAM) on embryonic day 17 (E17) produces behavioral and anatomical brain abnormalities, which model some aspects of schizophrenia. This ha...

    Eva Hradetzky, Thomas M Sanderson, Tsz M Tsang, John L Sherwood in Neuropsychopharmacology (2012)

  6. Article

    Open Access

    The role of proteomics in depression research

    Depression is a severe neuropsychiatric disorder affecting approximately 10% of the world population. Despite this, the molecular mechanisms underlying the disorder are still not understood. Novel technologies...

    Daniel Martins-de-Souza, Laura W. Harris in European Archives of Psychiatry and Clinic… (2010)

  7. Article

    Open Access

    Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia

    Many critical maturational processes take place in the human brain during postnatal development. In particular, the prefrontal cortex does not reach maturation until late adolescence and this stage is associat...

    Laura W Harris, Helen E Lockstone, Phillipp Khaitovich in BMC Medical Genomics (2009)

  8. Article

    Open Access

    Metabolic changes in schizophrenia and human brain evolution

    Despite decades of research, the molecular changes responsible for the evolution of human cognitive abilities remain unknown. Comparative evolutionary studies provide detailed information about DNA sequence an...

    Philipp Khaitovich, Helen E Lockstone, Matthew T Wayland, Tsz M Tsang in Genome Biology (2008)

  9. No Access

    Article

    Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome

    Warburg Micro syndrome (WARBM1) is a severe autosomal recessive disorder characterized by developmental abnormalities of the eye and central nervous system and by microgenitalia. We identified homozygous inact...

    Irene A Aligianis, Colin A Johnson, Paul Gissen, Dongrong Chen in Nature Genetics (2005)